Scientists discover a hidden eye disease that slowly steals night vision
- Date:
- November 22, 2026
- Source:
- University of Pennsylvania School of Medicine
- Summary:
- Scientists have discovered a new genetic eye disease that can silently damage peripheral and night vision while leaving central sight largely unaffected for years. The condition may be detectable through an unusual difficulty adjusting to darkness, offering a potential early warning sign before irreversible retinal damage occurs.
- Share:
A newly identified genetic eye disease can gradually interfere with night vision and the ability to see objects at the edges of the visual field. The condition may be especially difficult to recognize because people can maintain good eyesight for much of their lives before noticeable problems develop.
An international research team, including scientists at the Scheie Eye Institute within the University of Pennsylvania's Perelman School of Medicine, traced the condition to a gene already associated with another form of vision loss. However, the two diseases affect eyesight in strikingly different ways. The previously known disorder primarily damages central vision, while the newly discovered condition affects peripheral vision and the ability to see in darkness.
Although the condition has not yet received an official name, researchers are calling it EFEMP1-associated late-onset retinal degeneration (L-ORD). It is linked to a specific genetic variant known as p.Arg140Trp in the EFEMP1 gene. This change causes an unusually thick accumulation of material between cells in the eye.
A Genetic Discovery That Began Decades Ago
The investigation traces back to 1998, when doctors documented an unusual pattern of vision loss in a family in the United States. As researchers uncovered new genetic evidence, they were able to connect those findings to families in Europe who showed similar symptoms.
The study, published in JAMA Ophthalmology, examined three unrelated families from different countries who carried the p.Arg140Trp variant. Their symptoms were compared with those of another family carrying a different change in the same gene, called p.Arg345Trp, which is associated with the previously recognized disease affecting central vision.
The international collaboration included researchers from Penn Medicine, the University of Edinburgh, the University of Basel, Charles University, and the University of Bonn.
At first, scientists suspected that the unusual symptoms in the original family might be caused by a different genetic disorder. Testing, however, failed to identify the variants responsible for that condition.
"The different disease expression in this family was thought to be similar to a condition caused by C1QTNF5 gene variants. However, none of the variants associated with that disease were found," said Artur V. Cideciyan, PhD, an ophthalmology researcher and co-director of the Center for Hereditary Retinal Degenerations. "Our collaborators then discovered a new variant in the EFEMP1 gene that normally causes a different disease where the macula, which is tied to central vision, is affected first."
How the New Eye Disease Affects Night Vision
The researchers found that the newly identified condition develops gradually in the outer regions of the retina. Located at the back of the eye, the retina detects incoming light and transforms it into signals that the brain uses to create visual images.
Unlike the previously known EFEMP1 disorder, which initially affects the macula and central vision, this newly identified disease begins in the peripheral retina. People may see normally for much of their lives before gradually noticing that their side vision is narrowing or that seeing in dim surroundings has become more difficult.
Problems may be particularly noticeable around dusk or at night, when the eyes must rely more heavily on specialized light-sensitive cells called rods.
One reason the disease is challenging to diagnose is that these cells may initially show no visible structural damage. The gradual progression of symptoms can make the condition even harder to recognize.
However, the researchers identified a potentially valuable early clue. In affected individuals, rod cells take unusually long to recover when the eyes move from bright surroundings into darkness. This abnormal response can be detected even when the retina still appears structurally normal.
"We can detect a major abnormality in the way rod photoreceptors recover in darkness with retinas that still look structurally intact," Cideciyan said. "This gives us a functional marker of disease at a stage when photoreceptor cells have not yet been lost."
The finding suggests that changes in how the retina functions may reveal the disease before the light-sensitive cells responsible for vision begin to disappear.
What the Discovery Could Mean for Age-Related Vision Loss
An important question remains unanswered: How many people carry this newly identified genetic variant?
Researchers suspect the condition is relatively uncommon, but they do not yet have enough information to determine its prevalence. Larger investigations will be necessary to establish how frequently the variant occurs and how many people may be affected.
Beyond identifying another inherited eye disorder, the findings could help scientists better understand why vision deteriorates with age. Studying rare genetic diseases can reveal biological processes that may also contribute to much more widespread retinal conditions.
"Aging is a risk factor for many medical conditions, including retinal diseases such as age-related macular degeneration, the most common retinal condition of aging," said Tomas S. Aleman, MD, a professor of ophthalmology and the other co-director of the Center for Hereditary Retinal Degenerations. "Lessons learned from these infrequent, late-onset genetic eye diseases offer glimpses at possible mechanisms of disease for much more frequent retinal problems."
By revealing how different changes in a single gene can produce distinct patterns of vision loss, the research adds to scientists' understanding of inherited retinal disease. It also highlights the potential importance of detecting changes in visual function before damage becomes apparent in the retina's structure.
The study received support from the University of Edinburgh Chancellor's Fellowship award, RS Macdonald Charitable Trust Seedcorn Award, the BrightFocus Foundation (M2024009N), the German Research Foundation (532367710), the Medical Research Council (MC_UU_00035/9, MC_UU_00007/10), the Swiss National Science Foundation (204285), the Ministry of Health of the Czech Republic (NW24-06-00083), Charles University in Prague (UNCE/24/MED/022 and SVV 2600631), and the Samuel G. Jacobson, MD, PhD, Memorial Fund.
Story Source:
Materials provided by University of Pennsylvania School of Medicine. Note: Content may be edited for style and length.
Journal Reference:
- Chloe M. Stanton, Georg Ansari, Kristina Pfau, Theresa Lipsky, Mihail Halachev, Lukas Gerasimavicius, Camilla Drake, Joseph A. Marsh, Caroline Hayward, Alexander Sumaroka, Bohdan Kousal, Petra Lišková, Mathieu Quinodoz, Carlo Rivolta, Tomas S. Aleman, Artur V. Cideciyan, Maximilian Pfau. Widening the Spectrum of Disease Expression due to Heterozygous Variants in EFEMP1. JAMA Ophthalmology, 2026; 144 (10): 915 DOI: 10.1001/jamaophthalmol.2026.3828
Cite This Page: